X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Marico: Its 'Kaya' improvement continues - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Nov 9, 2004

    Marico: Its 'Kaya' improvement continues

    Introduction to results
    Edible and hair oil major, Marico, has continued its double digit performance in the September quarter. The company has clocked nearly 15% growth in consolidated revenues led by strength in its consumer care business. Operating margins seem under some pressure as compared to last year. However, lower tax outgo helped the company post nearly 20% growth in bottomline. The company finished the first half of FY05 with nearly 16% revenue growth and 20% bottomline growth.

    (Rs m) 2QFY04 2QFY05 Change 1HFY04 1HFY05 Change
    Net Sales 2,223 2,555 14.9% 4,315 4,994 15.7%
    Expenditure 2,036 2,345 15.2% 3,932 4,563 16.0%
    Operating profit (EBDITA) 187 210 11.9% 383 431 12.5%
    EBDITA margin (%) 8.4% 8.2%   8.9% 8.6%  
    Other Income 7 4 -41.7% 14 7 -47.4%
    Interest 3 6 125.9% 8 10 32.0%
    Depreciation 34 31 -7.5% 64 62 -3.6%
    Profit before Tax and minority interest 158 177 11.6% 325 366 12.7%
    Minority interest 4 7 47.7% 10 12 29.2%
    Tax 27 21 -22.8% 57 46 -19.0%
    Profit after Tax 136 163 19.6% 278 332 19.7%
    Net profit margin (%) 6.1% 6.4%   6.4% 6.7%  
    Effective tax rate (%) 16.9% 11.7%   17.5% 12.6%  
    No. of Shares (m) 58.0 58.0   58.0 58.0  
    Diluted earnings per share* (x) 9.4 11.2   9.6 11.5  
    P/E ratio (x)   12.7     12.4  
    (* annualised)            

    What is the company’s business?
    Marico is the market leader in the Rs 5 bn plus branded Indian coconut hair oil market with over 55% market share (Parachute). In edible oils, the company’s brands ‘Sweekar’ and ‘Saffola’ occupy the No. 2 position, with 13% share of this Rs 14 bn market. The company has also extended its ‘Parachute’ brand to the value added oil category (Parachute Jasmine). The brand is now No. 2 in this category with a 31% market share. ‘Hair & Care’, Marico’s non-sticky hair oil brand is also No. 2 in its category. Apart from oils, Marico’s product range also includes Mediker (Anti lice shampoo and oil – 100% share), Jams (Sil – 8% share) and fabric starch (Revive – nearly 100% share). Over the past two years, Marico has entered the skin care related businesses by acquiring 63% stake (currently 75.5% stake) in ‘Sundari’ range of ayurvedic skin care products in the US (revenues US$ 1 m), as well as rolling out 21 skin care clinics under the brand ‘Kaya’.

    What has driven performance in 2QFY05?
    Sales:  Growth was a mix of volume and value gains during the September quarter. Flagship brand 'Parachute' grew 14% in value terms, although volumes were nearly flat YoY. Value added hair oils portfolio (Parachute Jasmine, Hair & Care and Shanti Amla) largely led the growth for the company during the quarter. The folio grew by 22% in volume terms (27% value terms). In edible oils, Saffola franchise volumes grew by a strong 14% led by the launch of 'Saffola Gold' (a premium product). On the whole volumes grew by 8.5% on a like to like basis during the September quarter.

    Kaya plus Sundari
    (Rs m) 2QFY04 2QFY05 Change 1HFY04 1HFY05 Change
    Kaya Clinic            
    Revenues 9.6 38.1 296.9% 14.7 67.9 361.9%
    Loss -12.1 -12.4   -20.5 -22.1  
    Sundari Llc            
    Revenues 9.2 11.2 21.7% 21 21.5 2.4%
    Loss -7.5 -11.4   -16.2 -18.2  
    Total revenues (Kaya + Sundari Llc) 18.8 49.3 162.2% 35.7 89.4 150.4%
    Total loss (Kaya + Sundari Llc) -19.6 -23.8   -36.7 -40.3  

    Marico's international business continued its enthusing run. The business grew by a strong 34% during the quarter and now contributes 10% to the company's consolidated turnover. In Bangladesh, Parachute consolidated its market leadership with a 48% share of the market (up from 39% in 2QFY04). Apart from this, its new businesses (Kaya Skin Clinics and Sundari Ayurvedic) more than doubled their combined turnover to nearly Rs 50 m during the quarter. The management is growing its Kaya Clinics network at a fast pace. It has opened 7 clinics each in Mumbai and Delhi, 2 in Pune, 3 in Bangalore and 2 in Dubai, taking the total Kaya Clincs to 21. It will soon be opening up branches in Hyderbad and Chennai too.

    Cost break-up
    as a % of net sales 2QFY04 2QFY05 1HFY04 1HFY05
    Total Cost of goods 63.2% 62.8% 63.1% 62.0%
    Staff Cost 5.1% 5.5% 5.2% 5.3%
    Advertising 9.4% 10.2% 8.8% 10.1%
    Other Expenditure 13.9% 13.3% 14.1% 14.0%
    Total Expenditure 91.6% 91.8% 91.1% 91.4%

    Operating margins:  Increase in advertising costs as percentage of sales to over 10% during the quarter and the half year period, seems the key reason for the marginal dip in operating margins. However, total cost of goods and other expenditure were down marginally. The growth of nearly 20% in bottomline was largely driven by the strength in the topline. Lower tax provisioning added to the company's profit growth. Though new businesses of Kaya Clinics and Sundari Ayurvedics continued to eat into the consolidated profits (combined losses stood Rs 24 m in 2QFY05), the businesses are improving operationally. The quantum of losses has reduced when compared with the growth in revenues.

    Over the last five quarters
      2QFY04 3QFY04 4QFY04 1QFY05 2QFY05
    Sales growth (YoY) 15.2% 17.4% 11.9% 16.6% 14.9%
    Advertising as % of sales 9.4% 8.0% 8.4% 10.0% 10.2%
    OPM (%) 8.5% 8.6% 7.4% 9.1% 8.2%
    Net profit growth (YoY) 3.4% 5.9% 4.2% 19.0% 19.6%

    What to expect?
    Marico has declared its second interim dividend at Rs 1.2 per share. At Rs 142 the stock trades at 12.4 times annualised 1HFY05 earnings and market cap. to sales of 0.8x. Keeping in mind the continuous double digit turnover growth that the company has been able to maintain, led by new products and international markets, the valuations look attractive. The management's continuous flow of bonuses and dividends is also a sign of shareholder friendliness.

     

     

    Equitymaster requests your view! Post a comment on "Marico: Its 'Kaya' improvement continues". Click here!

      
     

    More Views on News

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    Marico: Margin Expansion Drives Profit Growth (Quarterly Results Update - Detailed)

    Nov 28, 2016

    Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.

    Marico: Profiting From Lower Input Cost Scenario (Quarterly Results Update - Detailed)

    May 6, 2016

    Marico announced results for the quarter and year ended March 2016. While revenues rose by 7% YoY during the year, net profits increased by 26% YoY.

    Marico: Volume Growth Makes a Comeback (Quarterly Results Update - Detailed)

    Mar 2, 2016

    Marico announced results for the quarter ended December 2015. While revenues rose by 7% YoY, net profits increased by 24% YoY.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    MARICO LTD SHARE PRICE


    Aug 18, 2017 (Close)

    TRACK MARICO LTD

    • Track your investment in MARICO LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    MARICO LTD 5-YR ANALYSIS

    Detailed Financial Information With Charts

    COMPARE MARICO LTD WITH

    MARKET STATS